Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
Royal Marsden NHS Foundation Trust · St James's University Hospital · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
554
total citations
- FWCI
- 33.18
- Percentile
- 100%
- References
- 38
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- Vincristine
- CHOP
- Rituximab
- Medicine
- Prednisolone
- Cyclophosphamide
- Gastroenterology
- Lymphoma
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.